User profiles for Laura Montrreal
 | Laura Montrreal NavarroVerified email at fundacioace.org Cited by 1656 |
[HTML][HTML] Common variants in Alzheimer's disease and risk stratification by polygenic risk scores
…, A Zettergren, I Hernández, L Montrreal… - Nature …, 2021 - nature.com
Genetic discoveries of Alzheimer’s disease are the drivers of our understanding, and together
with polygenetic risk stratification can contribute towards planning of feasible and efficient …
with polygenetic risk stratification can contribute towards planning of feasible and efficient …
Genome‐wide association analysis of dementia and its clinical endophenotypes reveal novel loci associated with Alzheimer's disease and three causality networks …
…, I Hernández, I Quintela, L Montrreal… - Alzheimer's & …, 2019 - Wiley Online Library
Introduction Large variability among Alzheimer's disease (AD) cases might impact genetic
discoveries and complicate dissection of underlying biological pathways. Methods Genome …
discoveries and complicate dissection of underlying biological pathways. Methods Genome …
[HTML][HTML] Genome-wide meta-analysis for Alzheimer's disease cerebrospinal fluid biomarkers
…, W Maier, M Marquié, MO Mol, L Montrreal… - Acta …, 2022 - Springer
Amyloid-beta 42 (Aβ42) and phosphorylated tau (pTau) levels in cerebrospinal fluid (CSF)
reflect core features of the pathogenesis of Alzheimer’s disease (AD) more directly than …
reflect core features of the pathogenesis of Alzheimer’s disease (AD) more directly than …
[HTML][HTML] Neuropsychiatric profiles and conversion to dementia in mild cognitive impairment, a latent class analysis
Neuropsychiatric symptoms (NPS) have been recently addressed as risk factors of conversion
to Alzheimer’s disease (AD) and other dementia types in patients diagnosed with Mild …
to Alzheimer’s disease (AD) and other dementia types in patients diagnosed with Mild …
[HTML][HTML] Establishing In-House cutoffs of csf alzheimer's disease biomarkers for the AT (N) stratification of the Alzheimer center barcelona cohort
Background: Clinical diagnosis of Alzheimer’s disease (AD) increasingly incorporates CSF
biomarkers. However, due to the intrinsic variability of the immunodetection techniques used …
biomarkers. However, due to the intrinsic variability of the immunodetection techniques used …
[HTML][HTML] Association between retinal thickness and β-amyloid brain accumulation in individuals with subjective cognitive decline: Fundació ACE Healthy Brain Initiative
Background Optical coherence tomography (OCT) of the retina is a fast and easily accessible
tool for the quantification of retinal structural measurements. Multiple studies show that …
tool for the quantification of retinal structural measurements. Multiple studies show that …
Matrix metalloproteinase 10 is linked to the risk of progression to dementia of the Alzheimer's type
Alzheimer’s disease has a long asymptomatic phase that offers a substantial time window
for intervention. Using this window of opportunity will require early diagnostic and prognostic …
for intervention. Using this window of opportunity will require early diagnostic and prognostic …
[HTML][HTML] Harnessing acoustic speech parameters to decipher amyloid status in individuals with mild cognitive impairment
Alzheimer's disease (AD) is a neurodegenerative condition characterized by a gradual
decline in cognitive functions. Currently, there are no effective treatments for AD, underscoring …
decline in cognitive functions. Currently, there are no effective treatments for AD, underscoring …
[HTML][HTML] The MAPT H1 Haplotype Is a Risk Factor for Alzheimer's Disease in APOE ε4 Non-carriers
An ancestral inversion of 900 kb on chromosome 17q21, which includes the microtubule-associated
protein tau (MAPT) gene, defines two haplotype clades in Caucasians (H1 and H2). …
protein tau (MAPT) gene, defines two haplotype clades in Caucasians (H1 and H2). …